China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market (2025-2031) | Growth, Industry, Value, Trends, Outlook, Share, Forecast, Analysis, Competitive Landscape, Size & Revenue, Companies, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, 2021 & 2031F

3.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Industry Life Cycle

3.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Porter's Five Forces

3.5 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By Drug type, 2021 & 2031F

3.6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By End user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in China

4.2.2 Growing investments in healthcare infrastructure and research development

4.2.3 Rising adoption of personalized medicine in cancer treatment

4.3 Market Restraints

4.3.1 High treatment costs associated with chimeric antigen receptor (CAR) T-cell therapy

4.3.2 Stringent regulatory requirements for approval and commercialization

4.3.3 Limited expertise in manufacturing and handling CAR T-cell therapies

6.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Drug type

6.1.1 Overview and Analysis

6.1.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Drug type, 2021- 2031F

6.1.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Axicabtagene Ciloleucel, 2021- 2031F

6.1.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Tisagenlecleucel, 2021- 2031F

6.1.5 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Brexucabtagene Autoleucel, 2021- 2031F

6.1.6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Others, 2021- 2031F

6.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Indication

6.2.1 Overview and Analysis

6.2.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Lymphoma, 2021- 2031F

6.2.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Acute Lymphocytic Leukemia, 2021- 2031F

6.2.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Others, 2021- 2031F

6.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By End user

6.3.1 Overview and Analysis

6.3.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Cancer Treatment Centers, 2021- 2031F

7.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Export to Major Countries

7.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Imports from Major Countries

8.1 Patient response rate to CAR T-cell therapy

8.2 Number of clinical trials and research studies conducted in China related to CAR T-cell therapy

8.3 Percentage of healthcare facilities offering CAR T-cell therapy treatments

9.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By Drug type, 2021 & 2031F

9.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By End user, 2021 & 2031F

10.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue Share, By Companies, 2024

10.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters